JENNIFER L GOODRICH
Allopathic & Osteopathic Physicians|Otolaryngology ROCKVILLE, MD NPI 1003077587
Browse related groups: Allopathic & Osteopathic Physicians|Otolaryngology MD GENZYME CORPORATION All categories
General Payments — all program years on this page
$414.52
- Category: General Payments
- Program years: PY2023–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $229.92 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.92 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $93.25 | 3 |
| Regeneron Healthcare Solutions, Inc. | $59.76 | 2 |
| REVANCE THERAPEUTICS, INC. | $39.91 | 1 |
| GlaxoSmithKline, LLC. | $37.00 | 2 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1114058224 | Regeneron Healthcare Solutions, Inc. | $34.89 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114058226 | Regeneron Healthcare Solutions, Inc. | $24.87 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116205556 | GlaxoSmithKline, LLC. | $16.69 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116277806 | GlaxoSmithKline, LLC. | $20.31 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139577400 | GENZYME CORPORATION | $31.35 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139577448 | GENZYME CORPORATION | $31.35 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139577488 | GENZYME CORPORATION | $30.55 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147919068 | REVANCE THERAPEUTICS, INC. | $39.91 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.